Integrated Filing — IndAS



General information about company

Scrip Code 540596
NSE Symbol ERIS
MSEI Symbol NOTLISTED
ISIN INE406M01024
Name of company Eris Lifesciences Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 20-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 15-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 20-05-2026   11:00:00
End date and time of board meeting 20-05-2026   14:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? Yes
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? Yes
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 07-08-2023
Indicate Company website link for updated RPT policy of the Company https://eris.co.in/corporate-governance/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 27,731.00 1,82,174.00
Other income 2,697.00 9,831.00
Total income 30,428.00 1,92,005.00
2 Expenses
(a) Cost of materials consumed 2,253.00 8,399.00
(b) Purchases of stock-in-trade 12,295.00 47,822.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (772.00) 6,449.00
(d) Employee benefit expense 7,867.00 34,062.00
(e) Finance costs 4,270.00 17,954.00
(f) Depreciation, depletion and amortisation expense 3,882.00 15,438.00
(f) Other Expenses
1 Other 3,910.00 24,209.00
Total other expenses 3,910.00 24,209.00
Total expenses 33,705.00 1,54,333.00
3 Total profit before exceptional items and tax (3,277.00) 37,672.00
4 Exceptional items 0.00 (1,467.00)
5 Total profit before tax (3,277.00) 36,205.00
6 Tax expense
7 Current tax (763.00) 6,096.00
8 Deferred tax (1,654.00) 5,704.00
9 Total tax expenses (2,417.00) 11,800.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (860.00) 24,405.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (860.00) 24,405.00
17 Other comprehensive income net of taxes 219.00 69.00
18 Total Comprehensive Income for the period (641.00) 24,474.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,385.00 1,385.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 3,18,161.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.63 17.86
Diluted earnings (loss) per share from continuing operations -0.63 17.83
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.63 17.86
Diluted earnings (loss) per share from continuing and discontinued operations -0.63 17.83
24 Debt equity ratio 0.6600 0.6600
25 Debt service coverage ratio 1.0300 1.7400
26 Interest service coverage ratio 0.2300 3.100
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 12,419.00
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 4,857.00
Other intangible assets 2,17,979.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 1,41,405.00
Trade receivables, non-current 0.00
Loans, non-current 45,651.00
Other non-current financial assets
1 Non current 26,593.00
Total of other non-current financial assets 26,593.00
Total non-current financial assets 2,13,649.00
Deferred tax assets (net) 22,636.00
Other non-current assets
1 Non current Tax asset (Net) 3,002.00
2 Other non-current assets 971.00
Total of other non-current assets 3,973.00
Total non-current assets 4,75,513.00
2 Current assets
Inventories 12,136.00
Current financial asset
Current investments 0.00
Trade receivables, current 30,716.00
Cash and cash equivalents 2,518.00
Bank balance other than cash and cash equivalents 258.00
Loans, current 50,034.00
Other current financial assets
Total of other current financial assets 298.00
Total current financial assets 83,824.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 6,321.00
Total of other current assets 6,321.00
Total current assets 1,02,281.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 5,77,794.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,385.00
Other equity 3,18,161.00
Total equity attributable to owners of parent 3,19,546.00
Non controlling interest
Total equity 3,19,546.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 79,762.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 48.00
2 lease liabilities 1,972.00
Total of other non-current financial liabilities 2,020.00
Total non-current financial liabilities 81,782.00
Provisions, non-current 4,693.00
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 86,475.00
Current liabilities
Current financial liabilities
Borrowings, current 1,27,794.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 513.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 21,422.00
Total Trade payable 21,935.00
Other current financial liabilities
1 Other current financial liabilities 16,087.00
2 Lease liabilites 586.00
Total of other current financial liabilities 16,673.00
Total current financial liabilities 1,66,402.00
Other current liabilities 2,591.00
1 Other current liabilities 2,591.00
Total of other current liabilities 2,591.00
Provisions, current 2,780.00
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 1,71,773.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 2,58,248.00
Total equity and liabilites 5,77,794.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Acturial 296.00 65.00
Total Amount of items that will not be reclassified to profit and loss 296.00 65.00
2 Income tax relating to items that will not be reclassified to profit or loss 77.00 (4.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 219.00 69.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 36,205.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 17,954.00
Adjustments for decrease (increase) in inventories 7,122.00
Adjustments for decrease (increase) in trade receivables, current (5,643.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 2,136.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 204.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 281.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 15,438.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (3,680.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 945.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 7,848.00
Adjustments for share-based payments 800.00
Adjustments for fair value losses (gains) (68.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 41.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 27,682.00
Net cash flows from (used in) operations 63,887.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 7,493.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 56,394.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 1,000.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 9.00
Purchase of property, plant and equipment 4,939.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 68.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 1,408.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (64,962.00)
Net cash flows from (used in) investing activities (69,416.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 40,230.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 448.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 6,244.00
Repayments of borrowings 22,266.00
Payments of lease liabilities 752.00
Dividends paid 0.00
Interest paid 18,116.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,318.00
Net cash flows from (used in) financing activities 7,106.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (5,916.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (5,916.00)
Cash and cash equivalents cash flow statement at beginning of period 8,434.00
Cash and cash equivalents cash flow statement at end of period 2,518.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Walker Chandiok &Co LLP Yes 31-05-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 35.00 0.00 0.00
2 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 12.00 0.00 0.00
3 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 29.00 0.00 0.00
4 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 4.00 0.00 0.00
5 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 834.00 0.00 0.00
6 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 1.00 0.00 0.00
7 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 1.00 0.00 0.00
8 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Royalty Income 0.00 NA 3.00 0.00 0.00
9 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 96.00 0.00 0.00
10 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 15.00 0.00 0.00
11 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 210.00 0.00 0.00
12 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 42.00 0.00 0.00
13 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Cross charge Income 0.00 NA 57.00 0.00 0.00
14 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 8.00 0.00 0.00
15 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Cross charge Income 28,792.00 Approved on 25-10-2025 8.00 0.00 0.00
16 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 8.00 0.00 0.00
17 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 38.00 0.00 0.00
18 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 1.00 0.00 0.00
19 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Cross charge Income 28,792.00 Approved on 25-10-2025 1.00 0.00 0.00
20 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 1.00 0.00 0.00
21 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 38.00 0.00 0.00
22 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Interest received 0.00 NA 29.00 0.00 0.00
23 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Interest received 0.00 NA 1.00 0.00 0.00
24 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Interest received 28,792.00 Approved on 25-10-2025 64.00 0.00 0.00
25 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Interest received 0.00 NA 437.00 0.00 0.00
26 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 83.00 0.00 0.00
27 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Interest received 0.00 NA 98.00 0.00 0.00
28 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Interest received 0.00 NA 790.00 0.00 0.00
29 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Interest received 28,792.00 Approved on 25-10-2025 46.00 0.00 0.00
30 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 6.00 0.00 0.00
31 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Interest received 0.00 NA 36.00 0.00 0.00
32 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Interest received 0.00 NA 689.00 0.00 0.00
33 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 181.00 0.00 0.00
34 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 86.00 0.00 0.00
35 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 30,360.00 0.00 0.00
36 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 1.00 0.00 0.00
37 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Sale of goods or services 28,792.00 Approved on 25-10-2025 1.00 0.00 0.00
38 ERIS THERAPEUTICS LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 108.00 0.00 0.00
39 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Sale of goods or services 0.00 NA 17,916.00 0.00 0.00
40 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 1.00 0.00 0.00
41 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Sale of goods or services 28,792.00 Approved on 25-10-2025 3,463.00 0.00 0.00
42 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 1,107.00 0.00 0.00
43 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 12.00 0.00 0.00
44 SWISS PARENTERALS LTD APRICA HEALTHCARE LTD Group Company Sale of goods or services 0.00 NA 22.00 0.00 0.00
45 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 28,792.00 Approved on 25-10-2025 41.00 0.00 0.00
46 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Royalty Income 0.00 NA 32.00 0.00 0.00
47 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 9.00 0.00 0.00
48 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 49.00 0.00 0.00
49 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 3.00 0.00 0.00
50 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 963.00 0.00 0.00
51 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 1.00 0.00 0.00
52 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Royalty Income 0.00 NA 2.00 0.00 0.00
53 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 96.00 0.00 0.00
54 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 20.00 0.00 0.00
55 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 180.00 0.00 0.00
56 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 42.00 0.00 0.00
57 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Cross charge Income 0.00 NA 55.00 0.00 0.00
58 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 8.00 0.00 0.00
59 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Cross charge Income 28,792.00 Approved on 25-10-2025 8.00 0.00 0.00
60 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 8.00 0.00 0.00
61 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 38.00 0.00 0.00
62 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 2.00 0.00 0.00
63 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Cross charge Income 28,792.00 Approved on 25-10-2025 2.00 0.00 0.00
64 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 2.00 0.00 0.00
65 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 37.00 0.00 0.00
66 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Interest received 0.00 NA 28.00 0.00 0.00
67 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Interest received 28,792.00 Approved on 25-10-2025 83.00 0.00 0.00
68 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 5.00 0.00 0.00
69 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 86.00 0.00 0.00
70 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Interest received 0.00 NA 96.00 0.00 0.00
71 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Interest received 0.00 NA 1,233.00 0.00 0.00
72 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Interest received 28,792.00 Approved on 25-10-2025 56.00 0.00 0.00
73 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Interest received 0.00 NA 35.00 0.00 0.00
74 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Interest received 0.00 NA 870.00 0.00 0.00
75 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 166.00 0.00 0.00
76 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 83.00 0.00 0.00
77 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 22,241.00 0.00 0.00
78 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 40.00 0.00 0.00
79 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Sale of goods or services 0.00 NA 26,617.00 0.00 0.00
80 ERIS THERAPEUTICS LTD SWISS PARENTERALS LTD Group Company Sale of goods or services 0.00 NA 151.00 0.00 0.00
81 ERIS THERAPEUTICS LTD APRICA HEALTHCARE LTD Group Company Sale of goods or services 0.00 NA 92.00 0.00 0.00
82 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 4.00 0.00 0.00
83 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 763.00 0.00 0.00
84 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Sale of goods or services 28,792.00 Approved on 25-10-2025 (960.00) 0.00 0.00
85 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge Income 0.00 NA 13.00 0.00 0.00
86 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Other current financial assets 0.00 NA 0.00 0.00 26,130.00
87 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 2,721.00
88 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 0.00 749.00
89 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 1,871.00
90 ERIS HEALTHCARE PVT LTD Eris Pharmaceuticals Limited Group Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 2.00
91 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 1.00
92 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 3,089.00
93 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 0.00 205.00
94 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 46,637.00
95 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 3.00
96 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 4,840.00
97 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 8,969.00
98 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 10,246.00
99 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 45,539.00
100 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 0.00 (25.00)
101 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 1.00
102 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 22.00
103 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 14.00
104 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Advance 0.00 NA 0.00 0.00 1.00
105 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 128.00
106 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 7.00
107 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 123.00
108 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Advance 0.00 NA 0.00 0.00 1.00
109 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Advance 0.00 NA 0.00 0.00 2.00
110 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 528.00
111 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 78.00
112 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 13,023.00
113 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 41.00
114 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 16.00
115 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 6,076.00
116 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 291.00
117 ERIS THERAPEUTICS LTD APRICA HEALTHCARE LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 5.00
118 ERIS THERAPEUTICS LTD SWISS PARENTERALS LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 158.00
119 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 47,795.00
120 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 (359.00)
121 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 490.00
122 ERIS HEALTHCARE PVT LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 7.00
123 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 287.00
124 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Advance 0.00 NA 0.00 0.00 2.00
125 ERIS M.J. BIOPHARM PVT LTD ERIS THERAPEUTICS LTD Group Company Advance 28,792.00 Approved on 25-10-2025 0.00 0.00 200.00
126 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Advance 0.00 NA 0.00 0.00 1.00
127 ERIS BIONXT PRIVATE LIMITED ERIS LIFESCIENCES LTD Holding Company Advance 0.00 NA 0.00 0.00 2.00
128 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 8.00
129 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 218.00
130 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Accrued interest receivable 0.00 NA 0.00 2.00 0.00
131 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Collection not due 0.00 NA 0.00 1.00 0.00
132 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 1,806.00 0.00
133 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Accrued interest receivable 0.00 NA 0.00 6.00 0.00
134 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Accrued interest receivable 28,792.00 Approved on 25-10-2025 0.00 54.00 0.00
135 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 2,009.00 0.00
136 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Accrued interest receivable 0.00 NA 0.00 7.00 0.00
137 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 13.00 0.00
138 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 275.00 0.00
139 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 22.00 0.00
140 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 8.00 0.00
141 ERIS HEALTHCARE PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 9.00 0.00
142 ERIS HEALTHCARE PVT LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 4.00 0.00
143 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 3.00 0.00
144 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 169.00 0.00
145 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 233.00 0.00
146 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Advance 28,792.00 Approved on 25-10-2025 0.00 1.00 0.00
147 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 4,824.00 0.00
148 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Advance 28,792.00 Approved on 25-10-2025 0.00 1.00 0.00
149 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 (836.00) 0.00
150 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 18.00 0.00
151 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 18.00 0.00
152 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 41.00 0.00
153 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Accrued interest receivable 0.00 NA 0.00 1,121.00 0.00
154 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 30,573.00 0.00
155 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 3,595.00 0.00
156 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Accrued interest receivable 0.00 NA 0.00 44.00 0.00
157 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 93.00 0.00
158 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 1.00 0.00
159 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 1,382.00 0.00
160 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 48,636.00 0.00
161 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Accrued interest receivable 28,792.00 Approved on 25-10-2025 0.00 81.00 0.00
162 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Collection not due 28,792.00 Approved on 25-10-2025 0.00 18.00 0.00
163 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 2,115.00 0.00
164 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 344.00 0.00
165 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Accrued interest receivable 0.00 NA 0.00 2,721.00 0.00
166 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 723.00 0.00
167 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 2,318.00 0.00
168 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 19,075.00 0.00
169 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Other current financial assets 0.00 NA 0.00 42,244.00 0.00
170 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 54.00 0.00
171 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 77.00 0.00
172 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 3.00 0.00
173 ERIS THERAPEUTICS LTD APRICA HEALTHCARE LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 11.00 0.00
174 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Accrued interest receivable 0.00 NA 0.00 189.00 0.00
175 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 35,474.00 0.00
176 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Accrued interest receivable 0.00 NA 0.00 3.00 0.00
177 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 113.00 0.00
178 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 4,845.00 0.00
179 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 231.00 0.00
180 ERIS THERAPEUTICS LTD ERIS OAKNET HELATHCATE PVT LTD Group Company Any other transaction Accrued interest receivable 0.00 NA 0.00 2.00 0.00
181 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 376.00 0.00
182 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 4,227.00 0.00
183 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 50.00 0.00
184 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 199.00 0.00
185 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 10,096.00 0.00
186 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 225.00 0.00
187 ERIS LIFESCIENCES LTD Amit Bakshi Promoter and Director Remuneration 500.00 Approved on 30-06-2025 0.00 25.00 0.00
188 ERIS LIFESCIENCES LTD Kaushal Shah Promoter and Director Remuneration 175.00 Approved on 30-06-2025 0.00 7.00 0.00
189 ERIS LIFESCIENCES LTD Inderjeet Singh Negi Promoter and Director Remuneration 130.00 Approved on 30-06-2025 0.00 10.00 0.00
190 ERIS LIFESCIENCES LTD Sarthak Negi Promoter Group Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 0.00 1.00 0.00
191 ERIS LIFESCIENCES LTD Parv Bakshi Promoter Group Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 0.00 3.00 0.00
192 SWISS PARENTERALS LTD Deutsche Labs Inc. Entity related to Mr. Naishadh Shah Any other transaction Trade receivable 0.00 NA 0.00 8.00 0.00
193 SWISS PARENTERALS LTD Healthbest Pvt.Ltd. Entity related to Mr. Naishadh Shah Any other transaction Trade payables 0.00 NA 0.00 3.00 0.00
194 SWISS PARENTERALS LTD Mr. Naishadh V Shah Director Remuneration 0.00 NA 0.00 24.00 0.00
195 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Loan repaid 0.00 NA 100.00 0.00 0.00
196 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Loan repaid 0.00 NA 125.00 0.00 0.00
197 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Loan repaid 0.00 NA 1,400.00 0.00 0.00
198 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
199 ERIS M.J. BIOPHARM PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan repaid 28,792.00 Approved on 25-10-2025 2,475.00 0.00 0.00
200 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 28,792.00 Approved on 25-10-2025 4,990.00 0.00 0.00
201 ERIS BIONXT PRIVATE LIMITED ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 0.00 NA 7,950.00 0.00 0.00
202 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
203 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Loan repaid 0.00 NA 145.00 0.00 0.00
204 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Loan Taken 0.00 NA 2,525.00 0.00 0.00
205 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Loan Taken 0.00 NA 600.00 0.00 0.00
206 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Wholly Owned Subsidiary Any other transaction Loan Taken 0.00 NA 0.00 0.00 0.00
207 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan Taken 0.00 NA 26,391.00 0.00 0.00
208 ERIS M.J. BIOPHARM PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan Taken 28,792.00 Approved on 25-10-2025 1,075.00 0.00 0.00
209 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan Taken 28,792.00 Approved on 25-10-2025 2,875.00 0.00 0.00
210 ERIS BIONXT PRIVATE LIMITED ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan Taken 0.00 NA 20,505.00 0.00 0.00
211 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan Taken 0.00 NA 1,616.00 0.00 0.00
212 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Loan Taken 0.00 NA 5,201.00 0.00 0.00
213 ERIS LIFESCIENCES LTD Amit Bakshi Promoter and Director Remuneration 500.00 Approved on 30-06-2025 246.00 0.00 25.00
214 ERIS LIFESCIENCES LTD Kaushal Shah Promoter and Director Remuneration 175.00 Approved on 30-06-2025 86.00 0.00 10.00
215 ERIS LIFESCIENCES LTD Inderjeet Singh Negi Promoter and Director Remuneration 130.00 Approved on 30-06-2025 64.00 0.00 7.00
216 ERIS LIFESCIENCES LTD Rajendra Patel Promoter Remuneration 0.00 NA 29.00 0.00 4.00
217 ERIS LIFESCIENCES LTD Krishnakumar Vaidyanathan Director Remuneration 0.00 NA 234.00 0.00 24.00
218 ERIS LIFESCIENCES LTD Parv Amit Bakshi Promoter Group Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 22.00 0.00 3.00
219 ERIS LIFESCIENCES LTD Sarthak Negi Promoter Group Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 3.00 0.00 1.00
220 ERIS BIONXT PRIVATE LIMITED Levim lifetech private limited Associate Company Any other transaction Loan Given 28,792.00 Approved on 25-10-2024 4,700.00 0.00 4,700.00
221 ERIS LIFESCIENCES LTD SHARDUL AMARCHAND MANGALDAS & Co Entity related to Director Purchase of goods or services 0.00 Approved under omnibus mechanism on 16-01-2026 58.00 0.00 0.00
222 ERIS M.J. BIOPHARM PVT LTD M.J. BIOPHARM PVT LTD Entity related to Director of Subsidiary Purchase of goods or services 28,792.00 Approved on 25-10-2025 1,084.00 1,811.00 462.00
223 SWISS PARENTERALS LTD Deutsche Labs Entity related to Director of Subsidiary Purchase of goods or services 0.00 NA 101.00 0.00 67.00
224 SWISS PARENTERALS LTD HealthBest Pvt. Ltd. Entity related to Director of Subsidiary Any other transaction rent 0.00 NA 17.00 0.00 1.00
225 SWISS PARENTERALS LTD Nucleus Formulation Entity related to Director of Subsidiary Purchase of goods or services 0.00 NA 32.00 0.00 0.00
Total value of transaction during the reporting period 1,94,928.00